Shufa Zheng

Zhejiang University-University of Edinburgh Institute

Also affiliated with First Affiliated Hospital Zhejiang University, Zhejiang University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study”.

Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study

Signal Transduction and Targeted Therapy(2024)10.1038/s41392-024-01941-x

N/A

0.483DataRank · unranked

24 citations

Apeng Yang, Jingke Yang, Sheng Zhang, Zhen Xing, Xingfu Wang +24 more

Influenza A-associated severe pneumonia in hospitalized patients: Risk factors and NAI treatments

International Journal of Infectious Diseases(2020)10.1016/j.ijid.2020.01.017

N/A

0DataRank · unranked

68 citations

Shufa Zheng, Xiaochen Wang, Sijia Liu, Jiaqi Bao, Fei Yu +16 more